BioNano Genomics Raises $53 Million Series C to Advance Genomic Mapping Technology to Reach the "Inaccessible Genome"
November 20, 2014BioNano Genomics raised $53M in a Series C round led by new investors Legend Capital and Novartis Venture Fund. Federated Kaufmann Fund, Monashee Investment Management, Domain Associates, Battelle Ventures and Gund Investment Corp. also participated.
More »
Zyga Technology Announces First Commercial Implantation and Publication of 12-month Clinical Study Data for Glyder Facet Restoration Device
November 19, 2014Zyga Technology completes the first Glyder Facet Restoration Device commercial surgery. They also published 12-month primary outcome data from their GLISSADE study that studied the Glyder system in the treatment of chronic facetogenic pain.
More »
Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline
November 17, 2014Clovis Oncology enters a clinical trial collaboration with GlaxoSmithKline LLC to evaluate a novel combination therapy of rociletinib and trametinib targeting mutant EGFR in non-small cell lung cancer. The Phase 1/2 trial is planned to start in 1H 2015.
More »